Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) — Cash Flow Reinvestment Rate
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a Cash Flow Reinvestment Rate of 0.26x as of September 2025, reinvesting CN¥22.77 Million (capex CN¥22.77 Million ) from operating cash flow of CN¥88.11 Million. Explore Zhejiang Wolwo Bio-Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd across 16 annual periods. Also explore total assets of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
Year-by-year capital reinvestment analysis for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market value of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.26x | CN¥593.90 Million | CN¥262.44 Million | CN¥117.97 Million | ▲ +119.1% |
| 2023 | 1.03x | CN¥401.03 Million | CN¥388.32 Million | CN¥209.16 Million | ▲ +74.4% |
| 2022 | 0.59x | CN¥213.34 Million | CN¥360.28 Million | CN¥188.74 Million | ▼ -7.7% |
| 2021 | 0.64x | CN¥231.21 Million | CN¥360.58 Million | CN¥122.16 Million | ▲ +69.1% |
| 2020 | 0.38x | CN¥97.16 Million | CN¥256.22 Million | CN¥70.16 Million | ▼ -85.8% |
| 2019 | 2.67x | CN¥620.83 Million | CN¥232.93 Million | CN¥99.83 Million | ▲ +127.6% |
| 2018 | 1.17x | CN¥241.75 Million | CN¥206.45 Million | CN¥57.75 Million | ▲ +5.4% |
| 2017 | 1.11x | CN¥176.73 Million | CN¥159.13 Million | CN¥34.73 Million | ▼ -1.6% |
| 2016 | 1.13x | CN¥138.50 Million | CN¥122.77 Million | CN¥35.93 Million | ▲ +85.1% |
| 2015 | 0.61x | CN¥69.97 Million | CN¥114.82 Million | CN¥31.51 Million | ▲ +125.0% |
| 2014 | 0.27x | CN¥22.67 Million | CN¥83.70 Million | CN¥22.67 Million | ▼ -9.9% |
| 2013 | 0.30x | CN¥17.53 Million | CN¥58.30 Million | CN¥17.53 Million | ▲ +70.8% |
| 2012 | 0.18x | CN¥7.25 Million | CN¥41.17 Million | CN¥7.25 Million | ▼ -15.6% |
| 2011 | 0.21x | CN¥3.99 Million | CN¥19.15 Million | CN¥3.99 Million | ▼ -71.3% |
| 2010 | 0.73x | CN¥10.56 Million | CN¥14.54 Million | CN¥10.56 Million | ▼ -57.3% |
| 2009 | 1.70x | CN¥21.48 Million | CN¥12.63 Million | CN¥21.48 Million | — |